Fluvoxamine
Drug / Medication
An antidepressant medication currently being studied in clinical trials for its potential anti-inflammatory and antioxidant properties in treating COVID-19.
Mentioned in 4 videos
Videos Mentioning Fluvoxamine

COVID Part 2: Masks, long COVID, boosters, mandates, treatments, and more
Peter Attia MD
An antidepressant that has shown dramatic reduction in mortality (91%) among compliant high-risk COVID patients in studies, but faces resistance for official NIH recommendation.

COVID-19: Current state of affairs, Omicron, and a search for the end game | Peter Attia, M.D.
Peter Attia MD
An existing drug discussed as reducing COVID-19 mortality by 91%.

The Science & Treatment of Obsessive Compulsive Disorder (OCD)
Andrew Huberman
A classic selective serotonin reuptake inhibitor (SSRI) used in OCD treatment.

COVID-19 Vaccines and Ivermectin with MedCram and Dr. Roger Seheult
FoundMyFitness
An antidepressant medication currently being studied in clinical trials for its potential anti-inflammatory and antioxidant properties in treating COVID-19.